- call +1-201-465-4211
- email sales@mrinsights.biz
Electroencephalogram (EEG) is used to diagnose brain disorders and visualizes the activity of the brain during a seizure. EEG evaluates people who are suffering from brain problems such as coma, confusions and tumors, difficulties in thinking and memory and weakening of specific parts of the body. Electromyography (EMG) measures the electrical activity of muscles at the time of rest and contraction. An EMG uses tiny devices called electrodes which help in transmission and detection of electrical signals. Evoked Potential devices are used to clinically diagnose a wide variety of central nervous system (CNS) diseases.
Scope of the Report:
In Europe, Germany, Italy, the U.K. and France holds major share of EEG, EMG and Evoked Potential devices market. However, Asia is expected to show high growth rates in the next five years in global EEG, EMG and Evoked Potential devices market. This is due to many companies constructing their R&D facilities in the region. In addition, increasing awareness about various neurological diseases is also supporting in the growth of EEG, EMG and Evoked Potential devices market in the region. Japan, China and India are expected to be the fastest growing EEG, EMG and Evoked Potential devices markets in Asia.
The global EEG,EMG and Evoked Potential Devices market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of EEG,EMG and Evoked Potential Devices.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the EEG,EMG and Evoked Potential Devices market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the EEG,EMG and Evoked Potential Devices market by product type and applications/end industries.
Market Segment by Companies, this report covers
Cadwell Laboratories (US)
Compumedics (Australia)
EB Neuro S.P.A. (Italy)
Electrical Geodesics (US)
Lifelines Neurodiagnostic Systems (US)
Natus Medical (US)
NeuroWave Systems (US)
Nihon Kohden (Japan)
Nihon Kohden America (US)
Noraxon (US)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Electroencephalography (EEG)
Electromyography (EMG)
Evoked Potential
Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers (ASCs)
Specialty Clinics
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 EEG,EMG and Evoked Potential Devices Market Overview
1.1 Product Overview and Scope of EEG,EMG and Evoked Potential Devices
1.2 Classification of EEG,EMG and Evoked Potential Devices by Types
1.2.1 Global EEG,EMG and Evoked Potential Devices Revenue Comparison by Types (2017-2023)
1.2.2 Global EEG,EMG and Evoked Potential Devices Revenue Market Share by Types in 2017
1.2.3 Electroencephalography (EEG)
1.2.4 Electromyography (EMG)
1.2.5 Evoked Potential
1.3 Global EEG,EMG and Evoked Potential Devices Market by Application
1.3.1 Global EEG,EMG and Evoked Potential Devices Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers (ASCs)
1.3.4 Specialty Clinics
1.3.5 Others
1.4 Global EEG,EMG and Evoked Potential Devices Market by Regions
1.4.1 Global EEG,EMG and Evoked Potential Devices Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) EEG,EMG and Evoked Potential Devices Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) EEG,EMG and Evoked Potential Devices Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) EEG,EMG and Evoked Potential Devices Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) EEG,EMG and Evoked Potential Devices Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) EEG,EMG and Evoked Potential Devices Status and Prospect (2013-2023)
1.5 Global Market Size of EEG,EMG and Evoked Potential Devices (2013-2023)
2 Manufacturers Profiles
2.1 Cadwell Laboratories (US)
2.1.1 Business Overview
2.1.2 EEG,EMG and Evoked Potential Devices Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Cadwell Laboratories (US) EEG,EMG and Evoked Potential Devices Revenue, Gross Margin and Market Share (2016-2017)
2.2 Compumedics (Australia)
2.2.1 Business Overview
2.2.2 EEG,EMG and Evoked Potential Devices Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Compumedics (Australia) EEG,EMG and Evoked Potential Devices Revenue, Gross Margin and Market Share (2016-2017)
2.3 EB Neuro S.P.A. (Italy)
2.3.1 Business Overview
2.3.2 EEG,EMG and Evoked Potential Devices Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 EB Neuro S.P.A. (Italy) EEG,EMG and Evoked Potential Devices Revenue, Gross Margin and Market Share (2016-2017)
2.4 Electrical Geodesics (US)
2.4.1 Business Overview
2.4.2 EEG,EMG and Evoked Potential Devices Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Electrical Geodesics (US) EEG,EMG and Evoked Potential Devices Revenue, Gross Margin and Market Share (2016-2017)
2.5 Lifelines Neurodiagnostic Systems (US)
2.5.1 Business Overview
2.5.2 EEG,EMG and Evoked Potential Devices Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Lifelines Neurodiagnostic Systems (US) EEG,EMG and Evoked Potential Devices Revenue, Gross Margin and Market Share (2016-2017)
2.6 Natus Medical (US)
2.6.1 Business Overview
2.6.2 EEG,EMG and Evoked Potential Devices Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Natus Medical (US) EEG,EMG and Evoked Potential Devices Revenue, Gross Margin and Market Share (2016-2017)
2.7 NeuroWave Systems (US)
2.7.1 Business Overview
2.7.2 EEG,EMG and Evoked Potential Devices Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 NeuroWave Systems (US) EEG,EMG and Evoked Potential Devices Revenue, Gross Margin and Market Share (2016-2017)
2.8 Nihon Kohden (Japan)
2.8.1 Business Overview
2.8.2 EEG,EMG and Evoked Potential Devices Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Nihon Kohden (Japan) EEG,EMG and Evoked Potential Devices Revenue, Gross Margin and Market Share (2016-2017)
2.9 Nihon Kohden America (US)
2.9.1 Business Overview
2.9.2 EEG,EMG and Evoked Potential Devices Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Nihon Kohden America (US) EEG,EMG and Evoked Potential Devices Revenue, Gross Margin and Market Share (2016-2017)
2.10 Noraxon (US)
2.10.1 Business Overview
2.10.2 EEG,EMG and Evoked Potential Devices Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Noraxon (US) EEG,EMG and Evoked Potential Devices Revenue, Gross Margin and Market Share (2016-2017)
3 Global EEG,EMG and Evoked Potential Devices Market Competition, by Players
3.1 Global EEG,EMG and Evoked Potential Devices Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 EEG,EMG and Evoked Potential Devices Players Market Share
3.2.2 Top 10 EEG,EMG and Evoked Potential Devices Players Market Share
3.3 Market Competition Trend
4 Global EEG,EMG and Evoked Potential Devices Market Size by Regions
4.1 Global EEG,EMG and Evoked Potential Devices Revenue and Market Share by Regions
4.2 North America EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
4.3 Europe EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
4.5 South America EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
5 North America EEG,EMG and Evoked Potential Devices Revenue by Countries
5.1 North America EEG,EMG and Evoked Potential Devices Revenue by Countries (2013-2018)
5.2 USA EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
5.3 Canada EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
5.4 Mexico EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
6 Europe EEG,EMG and Evoked Potential Devices Revenue by Countries
6.1 Europe EEG,EMG and Evoked Potential Devices Revenue by Countries (2013-2018)
6.2 Germany EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
6.3 UK EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
6.4 France EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
6.5 Russia EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
6.6 Italy EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
7 Asia-Pacific EEG,EMG and Evoked Potential Devices Revenue by Countries
7.1 Asia-Pacific EEG,EMG and Evoked Potential Devices Revenue by Countries (2013-2018)
7.2 China EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
7.3 Japan EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
7.4 Korea EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
7.5 India EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
8 South America EEG,EMG and Evoked Potential Devices Revenue by Countries
8.1 South America EEG,EMG and Evoked Potential Devices Revenue by Countries (2013-2018)
8.2 Brazil EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
8.3 Argentina EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
8.4 Colombia EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue EEG,EMG and Evoked Potential Devices by Countries
9.1 Middle East and Africa EEG,EMG and Evoked Potential Devices Revenue by Countries (2013-2018)
9.2 Saudi Arabia EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
9.3 UAE EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
9.4 Egypt EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
9.5 Nigeria EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
9.6 South Africa EEG,EMG and Evoked Potential Devices Revenue and Growth Rate (2013-2018)
10 Global EEG,EMG and Evoked Potential Devices Market Segment by Type
10.1 Global EEG,EMG and Evoked Potential Devices Revenue and Market Share by Type (2013-2018)
10.2 Global EEG,EMG and Evoked Potential Devices Market Forecast by Type (2018-2023)
10.3 Electroencephalography (EEG) Revenue Growth Rate (2013-2023)
10.4 Electromyography (EMG) Revenue Growth Rate (2013-2023)
10.5 Evoked Potential Revenue Growth Rate (2013-2023)
11 Global EEG,EMG and Evoked Potential Devices Market Segment by Application
11.1 Global EEG,EMG and Evoked Potential Devices Revenue Market Share by Application (2013-2018)
11.2 EEG,EMG and Evoked Potential Devices Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers (ASCs) Revenue Growth (2013-2018)
11.5 Specialty Clinics Revenue Growth (2013-2018)
11.6 Others Revenue Growth (2013-2018)
12 Global EEG,EMG and Evoked Potential Devices Market Size Forecast (2018-2023)
12.1 Global EEG,EMG and Evoked Potential Devices Market Size Forecast (2018-2023)
12.2 Global EEG,EMG and Evoked Potential Devices Market Forecast by Regions (2018-2023)
12.3 North America EEG,EMG and Evoked Potential Devices Revenue Market Forecast (2018-2023)
12.4 Europe EEG,EMG and Evoked Potential Devices Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific EEG,EMG and Evoked Potential Devices Revenue Market Forecast (2018-2023)
12.6 South America EEG,EMG and Evoked Potential Devices Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa EEG,EMG and Evoked Potential Devices Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure EEG,EMG and Evoked Potential Devices Picture
Table Product Specifications of EEG,EMG and Evoked Potential Devices
Table Global EEG,EMG and Evoked Potential Devices a
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
